We work with both large and small domestic and international pharmaceutical manufacturers and device makers prior to launch to assist in value proposition assessment and to determine the clinical utility of novel agents and devices. Post launch we assist in maximizing marketing opportunities and distribution outlets as well as aiding in the procurement of KOLs and speakers. Below are a few of the advisory services we provide:
- Advisory Boards
- Budget Impact Models
- Distribution Analysis
- Drug Development Strategies
- EMR Considerations
- Implementation Strategies
- KOL Procurement
- Market Position Analysis
- Phase II/III Value Proposition Development
- Physician/Hospital Integration Strategies
- Patient Assistance Considerations